Menstrual Bleeding in A Female Infant With Congenital Adrenal Hyperplasia: Altered Maturation of The Hypothalamic-Pituitary-Ovarian Axis
Menstrual Bleeding in A Female Infant With Congenital Adrenal Hyperplasia: Altered Maturation of The Hypothalamic-Pituitary-Ovarian Axis
Menstrual Bleeding in A Female Infant With Congenital Adrenal Hyperplasia: Altered Maturation of The Hypothalamic-Pituitary-Ovarian Axis
10
Journal of Clinical Endocrinology and Metabolism Printed in U.S.A.
Copyright © 1997 by The Endocrine Society
Departments of Pediatrics and Pediatric Endocrinology (N.U., D.C., R.D., F.M., K.P., S.O.), Pediatric
Radiology (N.G., K.R.), and Urology (E.S.), New York University Medical Center, New York, New York
10016
3298
MENSTRUAL BLEEDING IN AN INFANT WITH CAH 3299
TABLE 1. Sequential serum estradiol, FSH/LH, and FSH/LH response to GnRH stimulation
precursors was achieved on day 17 (17-hydroxyprogesterone, 36 ng/dL; an enhancing rim of tissue, suggesting that it most likely represented an
testosterone, 5 ng/dL; androstenedione, 21 ng/dL; PRA, 1.45 ng/mLzh; ovary (Fig. 2). A magnetic resonance imaging (MR) examination per-
Na, 140 mEq/L; K, 5.5 mEq/L; levels obtained about 6 h after the formed 3 days later showed a stimulated uterus measuring 4 cm in
morning dose of hydrocortisone) The infant was maintained on hydro- length (Fig. 3). In the right lower quadrant, small cysts adjacent to the
cortisone (2.5 mg every 8 h), 9a-fluorohydrocortisone (0.15 mg once dominant cyst confirmed the presence of a stimulated right ovary. To
daily), and sodium chloride (500 mg every 6 h). assess the activity of the hypothalamic-pituitary-ovarian axis, a GnRH
On day 88 of life, the infant had the onset of vaginal bleeding ac- stimulation test was performed. The results are presented in Table 1. At
companied by transient fever. Physical examination revealed ambigu- this time, the 17-hydroxyprogesterone level was 359 ng/dL, and the
ous genitalia as before, with no palpable breast buds and absent pubic androstenedione level was 26 ng/dL.
hair. Catheterization of the vagina yielded a minimal amount of blood. On the fifth hospitalization day, the infant was noted to have bilateral
Urine, blood, and cerebrospinal fluid cultures were negative for bacteria. breast buds, with glandular tissue measuring 0.75 cm on the right side
A pelvic ultrasound revealed the presence of a right ovary with a and 0.5 cm on the left side. She continued to have scant vaginal bleeding
dominant 3-cm cyst in the right lower quadrant, a stimulated uterus, and for a total of 12 days. During a follow-up visit on day 102 of life, she had
a fluid/debris-filled vaginal cavity (Fig. 1). A computed tomography smaller breast buds, measuring less than 0.5 cm bilaterally, and the
FIG. 3. Sagittal (A) and coronal (B) T2-weighted MR images (TR 6500 ms, TE 130 ms). The sagittal image demonstrates a debris/fluid-filled
vagina (straight arrow) and uterus with a prominent endometrium (curved arrow). On the coronal image, multiple small cysts (straight arrow)
and a large dominant cyst are indicative of an ovary in the right lower quadrant. A prominent lower uterine segment is also noted (curved arrow).
MENSTRUAL BLEEDING IN AN INFANT WITH CAH 3301
time revealed a persistently elevated estradiol level of 8.2 ng/dL, with Pelvic imaging studies
a FSH level of 10.0 mIU/mL and a LH level of 0.64 mIU/mL.
On day 109 of life, the infant still had palpable breast buds, measuring Pelvic ultrasound was performed on day 88 (Fig. 1), CT on
less than 0.5 cm bilaterally, and was thriving. The GnRH stimulation test day 89 (Fig. 2), and MR on day 92 (Fig. 3). They demonstrated
was repeated (see Table 1). Serum 17-hydroxyprogesterone was 62 ng/ a stimulated uterus with a prominent endometrial echo, mea-
dL, and testosterone was less than 3 ng/dL. Pelvic sonogram performed suring approximately 2.5 mm in the antero-posterior direc-
on the same day revealed the uterus to measure 3.8 cm in length, with
an identifiable endometrial echo. The right ovary was smaller and now tion, a fluid- and debris-filled vagina, and a stimulated right
measured 2.2 3 1.4 3 1.5 cm and contained multiple cysts. However, the ovary with a dominant 3-cm cyst. (MR was helpful, in that
dominant cyst was no longer seen. The left ovary was not definitively the small cysts confirming the presence of ovarian tissue
identified. Apart from minimal spotting on one diaper on day 114 of life, were not appreciated on either the ultrasound or the CT.) A
she had no more episodes of vaginal bleeding.
Three weeks after cessation of the vaginal bleeding, on day 127 of life,
follow-up ultrasound on day 109 (not shown) demonstrated
a follow-up pelvic sonogram was performed, and the uterus was noted the uterus and ovary to be less prominent, and the dominant
in the right ovary, the clinical course indicates an ovarian androgen suppression led to a marked rise in gonadotropin
response to exaggerated pituitary gonadotropin activity. At levels, resulting in significant stimulation of the existing
the time that breast development was noted, serum estradiol ovarian gonadotropin receptors. Growth of the ovarian fol-
was continuing to rise; it reached a maximum level 2 weeks licles and estrogen secretion subsequently occurred and
after the onset of uterine bleeding and declined thereafter. A manifested clinically as thelarche and endometrial bleeding.
reduction in the size of the ovary with nonvisualization of the Further studies of the ontogeny of fetal gonadal development
dominant cyst and a regression of breast size followed the in humans are needed to allow better understanding of our
decline in estradiol levels. Indeed, 14 months after the bleed- patient’s findings.
ing episode, she remains prepubertal with estradiol levels
below 0.5 ng/dL. A repeat GnRH test demonstrated the Acknowledgments
preservation of FSH predominance while maintaining brisk
responses to both FSH and LH. This is in keeping with the We thank Dr. Natalie Geary for her help with the evaluation of this